Skip to content
PoliticalRepoPoliticalRepo

Subjects · United States

Healthcare

Records whose title is actually about this topic. Use a country filter if the list is still too broad.

651 records in US in 2026

All countriesUnited States · 38,231Austria · 12,266Ireland · 11,064Netherlands · 4,600Germany · 1,149United Kingdom · 1,134European Union · 715France · 121Belgium · 4Search this topic

Records

Bill· HRH.R. 8055 (119th)referred

Extending WIC for New Moms Act

United States · United States Congress · 24 March 2026

Extending WIC for New Moms Act This bill amends the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) to extend the eligibility periods for breastfeeding and postpartum women. Specifically, a state program may elect to certify a breastfeeding woman for up to 24 months (currently 1 year) postpartum. The bill also expands the eligibility period for postpartum women to up to 24 months after termination of pregnancy (currently 6 months). The Department of Agriculture must submit a report to Congress evaluating the effect of these changes to the program on (1) maternal and infant health outcomes, (2) breastfeeding rates, and (3) qualitative evaluations of family experiences under WIC. 

Resolution· SRESS.Res. 656 (119th)passed

A resolution designating the third week of March 2026 as "National CACFP Week".

United States · United States Congress · 22 March 2026

This resolution designates the week beginning on March 15, 2026, as National CACFP Week. It also recognizes the role of the Child and Adult Care Food Program (CACFP) in improving the health of the children and adults in child care centers, family day care homes, emergency shelters, adult day care facilities, and after-school care in the United States by providing nutritious meals and snacks.

Bill· HRH.R. 8032 (119th)referred

FAIC Act

United States · United States Congress · 20 March 2026

Bill· SS. 4153 (119th)referred

Forever Chemical Regulation and Accountability Act of 2026

United States · United States Congress · 19 March 2026

Forever Chemical Regulation and Accountability Act of 2026 This bill phases out the release and nonessential use of perfluoroalkyl or polyfluoroalkyl substances (PFAS) and addresses PFAS research, remediation, regulation, and enforcement. The Environmental Protection Agency (EPA) must require each manufacturer and user of PFAS to submit annual reports that include specified information about the essential (e.g., critical for health or safety reasons) and nonessential uses of PFAS by such entities. Not later than 10 years after the enactment of this bill, manufacturers and users must fully phase out nonessential uses of PFAS. The bill also establishes specified deadlines to phase out the sale of certain products containing PFAS; requires federal agencies, to the maximum extent practicable, to eliminate the procurement of products known to contain PFAS; imposes a 10-year phaseout of the release of PFAS above a certain threshold of detection; provides enforcement authority to the EPA regarding violations of the requirements of the bill, including through civil and criminal penalties; allows citizen suits against manufacturers and users of PFAS and the EPA; and addresses actions under state law related to damages from exposure to hazardous substances, including with regard to statutes of repose. The bill exempts from a bankruptcy petition’s automatic stay any proceeding against a non-debtor entity (e.g., a proceeding to obtain property from a non-debtor) with respect to a PBT claim (a claim relating to persistent, bioaccumulative, and toxic chemicals) against the non-debtor entity, the debtor, or the estate.

Bill· HRH.R. 8016 (119th)referred

Forever Chemical Regulation and Accountability Act of 2026

United States · United States Congress · 19 March 2026

Forever Chemical Regulation and Accountability Act of 2026 This bill phases out the release and nonessential use of perfluoroalkyl or polyfluoroalkyl substances (PFAS) and addresses PFAS research, remediation, regulation, and enforcement. The Environmental Protection Agency (EPA) must require each manufacturer and user of PFAS to submit annual reports that include specified information about the essential (e.g., critical for health or safety reasons) and nonessential uses of PFAS by such entities. Not later than 10 years after the enactment of this bill, manufacturers and users must fully phase out nonessential uses of PFAS. The bill also establishes specified deadlines to phase out the sale of certain products containing PFAS; requires federal agencies, to the maximum extent practicable, to eliminate the procurement of products known to contain PFAS; imposes a 10-year phaseout of the release of PFAS above a certain threshold of detection; provides enforcement authority to the EPA regarding violations of the requirements of the bill, including through civil and criminal penalties; allows citizen suits against manufacturers and users of PFAS and the EPA; and addresses actions under state law related to damages from exposure to hazardous substances, including with regard to statutes of repose. The bill exempts from a bankruptcy petition’s automatic stay any proceeding against a non-debtor entity (e.g., a proceeding to obtain property from a non-debtor) with respect to a PBT claim (a claim relating to persistent, bioaccumulative, and toxic chemicals) against the non-debtor entity, the debtor, or the estate.

Bill· HRH.R. 8018 (119th)referred

ISLET Act

United States · United States Congress · 19 March 2026

Bill· HRH.R. 8011 (119th)referred

SECURE Health Act

United States · United States Congress · 19 March 2026

Bill· HRH.R. 7973 (119th)referred

Momnibus Act

United States · United States Congress · 18 March 2026

Bill· SS. 4109 (119th)open

Stem Cell Therapeutic and Research Reauthorization Act of 2026

United States · United States Congress · 17 March 2026

Stem Cell Therapeutic and Research Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA). The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research. The bill also expands periodic reviews of the state of stem cell science to specifically include a review of the use of high-quality cord blood units and other emergent technologies to develop new therapies for potential inclusion in the program. Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.

Resolution· HRESH.Res. 1118 (119th)referred

Expressing support for the designation of the third week of March as "National CACFP Week".

United States · United States Congress · 17 March 2026

This resolution recognizes the role of the Child and Adult Care Food Program (commonly referred to as CACFP) in improving the health of the country's most vulnerable children and adults in Head Start programs, child care programs, family day care homes, emergency shelters, adult day care programs, and after-school care by providing nutritious meals and snacks. It also supports the designation of National CACFP Week.

Bill· HRH.R. 7953 (119th)referred

FAIR ACT

United States · United States Congress · 17 March 2026

Bill· SS. 4103 (119th)referred

Save Our Sequoias Act

United States · United States Congress · 16 March 2026

Save Our Sequoias Act This bill provides for the conservation of giant sequoia trees ( Sequoiadendron giganteum ) in California. Specifically, it provides statutory authority for the Giant Sequoia Lands Coalition and outlines the coalition's duties. The coalition must submit a Giant Sequoia Health and Resiliency Assessment and annually update it. The information from the assessment must be made available so the information can be integrated into certain other plans. The coalition must also create and maintain a website that contains the assessment, educational materials, searchable information about individual giant sequoia groves, and a searchable database to track the status and costs of reforestation and rehabilitation activities. Finally, the coalition must also have an annual public meeting. In addition, the bill declares an emergency on certain public lands and allows officials to carry out protection plans during the emergency to respond to the threat of wildfires, insects, and drought. The emergency expires after seven years. The Department of the Interior must develop and implement a Giant Sequoia Reforestation and Rehabilitation Strategy. Interior and the Forest Service must develop and implement a strategy for monitoring insects in giant sequoia groves with a high-risk or previous history of insect infestations. They must also enter into public-private partnerships to deploy technology to assist in monitoring infestations. Finally, the bill establishes a variety of programs and funds to support the conservation of giant sequoias.

Bill· HRH.R. 7947 (119th)referred

Agricultural Management Assistance Act of 2026

United States · United States Congress · 16 March 2026

Agricultural Management Assistance Act of 2026 This bill expands and revises the Agricultural Management Assistance (AMA) programs, which help agricultural producers manage financial risk through diversification, marketing, or natural resource conservation practices. (AMA is available in 16 designated states where participation in the Federal Crop Insurance Program is historically low.) Specifically, the bill expands the eligible uses for financial assistance funds for producers to include soil health improvements, the development of sustainable water sources and irrigation, composting, and other conservation practices determined to reduce the risk to a farm of financial loss due to the regional impacts of climate change. The bill also specifies that funds provided to mitigate financial risk through production or marketing diversification may be used for food safety certification. The bill provides additional funding for the program and changes the payment limitation for farmers to $200,000 over five years (currently $50,000 per year). The bill also expands those eligible for assistance under AMA programs to include federal crop insurance providers, in particular providers of Whole-Farm Revenue Protection plans.

Bill· HRH.R. 7931 (119th)referred

IDA Act of 2026

United States · United States Congress · 12 March 2026

Bill· HRH.R. 7909 (119th)referred

Medicare Expansion and Lowering Costs Now Act

United States · United States Congress · 12 March 2026

Medicare Expansion and Lowering Costs Now Act This bill establishes a Medicare buy-in option for certain qualifying individuals and makes a series of other changes relating to health care costs. It also repeals the health provisions that were enacted under what is commonly known as the One Big Beautiful Bill Act. Specifically, the bill allows individuals aged 50 to 64 to enroll in Medicare if such individuals would otherwise qualify for Medicare at the age of 65. The Centers for Medicare & Medicaid Services (CMS) must determine enrollment periods and set premiums for the buy-in option established under the bill, in accordance with specified requirements. The CMS must also award grants to states and nonprofit organizations for outreach and enrollment activities relating to the buy-in option. Additionally, the bill repeals the health provisions that were enacted under what is commonly known as the One Big Beautiful Bill Act. Among other provisions, the act required individuals who are eligible for Medicaid as part of the Medicaid expansion population to engage in community service, work, or other activities in order to qualify for Medicaid. (For more information about these and other health provisions in the act, see CRS Report R48633 .) The bill also (1) establishes a supplemental option under Medicare to cover cost-sharing for beneficiaries; (2) establishes an individual market reinsurance program relating to coverage of high-cost individuals, as specified; and (3) expands eligibility for the premium tax credit.

Bill· HRH.R. 7906 (119th)referred

FOOD for Health Act

United States · United States Congress · 12 March 2026

Bill· SS. 4048 (119th)referred

PREDICT Act

United States · United States Congress · 11 March 2026

Bill· SS. 4036 (119th)referred

AADAPT Act

United States · United States Congress · 10 March 2026

Bill· SS. 4037 (119th)referred

Diabetes Act

United States · United States Congress · 10 March 2026

PreviousPage 13 of 14Next